Ignite Creation Date:
2024-05-06 @ 7:40 PM
Last Modification Date:
2024-10-26 @ 3:11 PM
Study NCT ID:
NCT06094907
Status:
COMPLETED
Last Update Posted:
2024-05-08
First Post:
2023-10-10
Brief Title:
Safety Tolerability and Antidepressant Effects of DMT in Patients With Depression
Sponsor:
Universidade Federal do Rio Grande do Norte
Organization:
Universidade Federal do Rio Grande do Norte
Study Overview
Official Title:
An Open Label Trial of Inhaled NN-Dimethyltryptamine in Patients With Partial Response in Depression
Status:
COMPLETED
Status Verified Date:
2024-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study aims to evaluate the acute and subacute effects of an inhaled N N-Dimethyltryptamine DMT in patients with partial response in depression
Detailed Description:
This is a phase II open-label single-ascending fixed-order study to assess the feasibility and efficacy of inhaled N N-Dimethyltryptamine DMT in patients with partial response in depression
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None